Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Macova 2.5 Tablet

Prescription Icon
Prescription Required

Marketer

Gynofem Healthcare Pvt. Ltd.

Salt Composition

Letrozole (2.5mg)

Overview Macova 2.5 Tablet

Postmenopausal women with breast cancer may find relief with Macova 2.5mg tablets. This medication can be a standalone treatment or used alongside other therapies like surgery or radiotherapy. In advanced breast cancer, it helps curb metastasis. Macova 2.5mg tablets can be administered with or without food, always following your doctor's prescribed dosage and duration for optimal results. Dosage frequency varies based on the specific treatment goal, determined by your physician to manage your symptoms effectively. Continue the medication as directed. Common side effects include increased sweating, fatigue, hot flushes, and elevated cholesterol. Report any concerning side effects to your doctor; management strategies are available. Prior to commencing treatment, inform your doctor of any existing liver or kidney conditions, osteoporosis history, and all other medications you are currently using, as interactions may affect Macova's efficacy. Disclose any pregnancy or breastfeeding status. Your doctor might order blood tests to assess vitamin D levels and bone density before and throughout the treatment period.

Uses of Macova 2.5 Tablet

Managing Breast Cancer

Major Benefits of Macova 2.5 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Macova 2.5 Tablet can be administered with or without food, although consistent timing is recommended.

Common Side effects of Macova 2.5 Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Macova 2.5 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or divide it. Macova 2.5 Tablet can be administered with or without food, however, consistent timing is recommended.

How Macova 2.5 Tablet works:

Femara 2.5mg tablets are classified as aromatase inhibitors. Their mechanism of action involves reducing the body's estrogen production. This lower estrogen level can inhibit or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse reactions from concurrent use of Macova 2.5 Tablet and alcohol.

PregnancyPregnancyUNSAFE

Using Macova 2.5 Tablet during pregnancy is strongly contraindicated. Pregnant women should consult their physician; animal and human studies indicate substantial risks to fetal development.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should not take Macova 2.5 Tablet. Evidence indicates potential infant harm from this medication.

DrivingDrivingUNSAFE

Taking Macova 2.5 Tablet may cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Macova 2.5 Tablet presents no need for dosage changes in patients with kidney impairment. Its use is considered safe in such cases. Nevertheless, data regarding its use in individuals with end-stage renal disease is scarce. Physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should use Macova 2.5mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Macova 2.5 Tablet :

Should you forget a Macova 2.5 Tablet dose, take it immediately. If, however, your next dose is imminent, omit the missed one and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Macova 2.5 Tablet

LabelValue
Chemical Type Diphenylmethane-based Compound
Developing Habits No.
Treatment Category Cancer Treatments

FAQs on Macova 2.5 Tablet

Macova 2.5 Tablets are an aromatase inhibitor, typically prescribed for postmenopausal women with breast cancer. This includes those who have stopped menstruating naturally or due to medical intervention.
Macova 2.5 Tablet is an aromatase inhibitor, a type of anti-estrogen medication. It works by blocking the aromatase enzyme, thereby decreasing estrogen production. Since estrogen fuels the growth of some breast cancers—termed "estrogen-dependent cancers"—lowering estrogen levels can help prevent cancer progression.
For advanced breast cancer or cancer that has spread, continue taking Macova 2.5 Tablet until tumor progression. Following tamoxifen or surgery, take Macova 2.5 Tablet for five years, or until recurrence, whichever occurs first. Alternatively, a sequential regimen of two years of Macova 2.5 Tablet followed by three years of tamoxifen may be used.
While irbesartan and Macova 2.5 Tablet can be taken together, monitor your blood pressure closely as Macova 2.5 Tablet may elevate it. Consult your doctor if blood pressure management becomes difficult.
While rare, Macova 2.5 Tablet may cause cataracts. Report blurred vision or eye irritation to your doctor promptly.
Experiencing hot flushes may indicate a common side effect of Macova 2.5 Tablet, related to lowered estrogen levels. These usually lessen as your body adapts, but may persist throughout treatment, subsiding a few months afterward. For significant discomfort, consult your doctor for appropriate management.
While rare, serious side effects of Macova 2.5 Tablet may include stroke, angina, heart attack, blood clots, cataracts, osteoporosis, and severe skin reactions.
Macova 2.5 Tablet can reduce bone density (osteoporosis) due to lowered estrogen levels. Your doctor may monitor your bone density with tests before, during, and after treatment.
The Ministry of Health and Family Welfare restricts Macova 2.5 Tablet use to ovulation induction in women with anovulatory infertility.
Macova 2.5 Tablet
194